NCT06930781

Brief Summary

This study is a combined retro- and prospective, single arm, multicentre investigation designed to follow clinical practice for Ponto-implantations performed out of OR. The overall objective is to investigate the complication rate for procedures performed out-of-OR.

Trial Health

83
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started May 2025

Geographic Reach
5 countries

6 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
May 2025Apr 2027

First Submitted

Initial submission to the registry

April 1, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 16, 2025

Completed
21 days until next milestone

Study Start

First participant enrolled

May 7, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2027

Expected
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

July 8, 2026

Status Verified

July 1, 2026

Enrollment Period

1.9 years

First QC Date

April 1, 2025

Last Update Submit

July 7, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intraoperative complications at surgery

    During the Ponto-implantation surgery

Secondary Outcomes (9)

  • Assessment of procedure room variables

    12 months after study start

  • To assess surgical parameters

    During Ponto-implantation surgery

  • Evaluation of patient experience of surgical procedure based on Ponto procedure questionnaire

    5-10 days after Ponto surgery

  • To assess postoperative events and complications

    From day of surgery, through study completion, an average of 1 year

  • To assess rate of implant survival

    3 months after surgery, and through study completion, an average of 1 year.

  • +4 more secondary outcomes

Study Arms (2)

Retrospective group

Data gathered from retrospective chart reviews of patients who have undergone Ponto-implantation in an out-of-OR setting from 2019 and onwards

Device: Ponto implantation

Prospective group

Patients who have undergone Ponto implantation in an out-of-OR setting and participated in the study by filling out questionnaires.

Device: Ponto implantation

Interventions

Ponto implantation is a surgical procedure to implant a bone-anchored hearing device, improving hearing by transmitting sound directly to the inner ear through bone conduction.

Prospective groupRetrospective group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Bone-conduction hearing device users

You may qualify if:

  • Adult subjects (≥18 years old) undergoing Ponto implantation in an out-of-OR setting from 2019 and onwards
  • Signed informed consent (applicable for subjects answering questionnaires)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Northern California Veterans Affairs Healthcare System

Sacramento, California, 95655, United States

RECRUITING

Clinical Hospital from the Ribeirão Preto Medical School

São Paulo, São Paulo, 3900, Brazil

ACTIVE NOT RECRUITING

Queen Elizabeth II Health Sciences Centre

Halifax, Nova Scotia, B3H 2Y9, Canada

RECRUITING

Hospital Virgen de las Nieves

Granada, Andalusia, 18014, Spain

ACTIVE NOT RECRUITING

Sunderby Sjukhus

Luleå, Norrbotten County, 971 80, Sweden

ACTIVE NOT RECRUITING

Skåne University Hospital

Lund, Skåne County, 22185, Sweden

ACTIVE NOT RECRUITING

MeSH Terms

Conditions

Hearing Loss

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Dr David Morris

    Queen Elizabeth II Health Sciences Centre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2025

First Posted

April 16, 2025

Study Start

May 7, 2025

Primary Completion (Estimated)

March 30, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

July 8, 2026

Record last verified: 2026-07

Locations